Inactive Instrument
CV Sciences, Inc. Stock Other OTC
Stocks
CVSI
US1266541028
Pharmaceuticals
OTC Markets Traded| Market Cap | 4.22M 3.64M 3.41M 3.12M 5.85M 402M 5.89M 40.46M 15.73M 204M 15.85M 15.51M 675M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.94M 5.12M 4.8M 4.39M 8.23M 565M 8.29M 56.92M 22.12M 287M 22.3M 21.82M 949M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.97% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript : CV Sciences, Inc.
| 1 day | -0.05% |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 2018-05-30 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 2019-03-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 2018-05-30 |
Jamie Corroon
BRD | Director/Board Member | 56 | 2022-07-20 |
William McCorkle
BRD | Director/Board Member | 58 | 2022-10-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.05% | -0.43% | - | - | 4.21M | ||
| -1.52% | -7.86% | +57.90% | +111.09% | 1,047B | ||
| -0.82% | -1.62% | +50.05% | +62.37% | 646B | ||
| +0.37% | -3.22% | +21.87% | +72.88% | 451B | ||
| -1.64% | -4.75% | +35.59% | +35.54% | 355B | ||
| -0.39% | -2.76% | +21.39% | +38.01% | 291B | ||
| -1.19% | -2.21% | +1.53% | +11.51% | 252B | ||
| -0.59% | -3.15% | +49.83% | +67.70% | 234B | ||
| -1.05% | -2.29% | -19.91% | -54.10% | 203B | ||
| +0.45% | -0.27% | +29.84% | +91.34% | 181B | ||
| Average | -0.37% | -2.68% | +27.56% | +48.48% | 406.59B | |
| Weighted average by Cap. | -0.12% | -3.46% | +36.91% | +64.88% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.52M 12.7M 11.6M 21.76M 1.49B 21.91M 150M 58.48M 758M 58.95M 57.68M 2.51B | 13.79M 11.87M 11.15M 10.18M 19.11M 1.31B 19.24M 132M 51.35M 666M 51.76M 50.64M 2.2B |
| Net income | -2.39M -2.06M -1.94M -1.77M -3.32M -228M -3.34M -22.94M -8.92M -116M -8.99M -8.79M -383M | -958K -825K -775K -707K -1.33M -91.16M -1.34M -9.18M -3.57M -46.24M -3.6M -3.52M -153M |
| Net Debt | 325K 280K 263K 240K 450K 30.92M 453K 3.11M 1.21M 15.69M 1.22M 1.19M 51.93M | 1.72M 1.48M 1.39M 1.27M 2.38M 163M 2.4M 16.46M 6.4M 82.92M 6.45M 6.31M 275M |
Employees
-
Sector
Pharmaceuticals
















